Premium
Indian pharmaceuticals giant Cipla Ltd that has scaled down its business in China over the last three-four years even as it has been aggressively looking at overseas acquisitions is now relooking at its strategy.The firm is contemplating significant new investments, including acquisitions, in China, a senior company executive told VCCircle.The ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
